Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer

Cai, Hui; Yuan, Yuan; Hao, Yun-Fei; Guo, Tian-Kang; Wei, Xue; Zhang, Ying-Mei
March 2013
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
Academic Journal
Recent studies have shown that microRNAs can be stably detected in human plasma and have the potential as non-invasive biomarkers for the diagnosis of cancers. This study evaluates the potential application of plasma microRNAs for the early detection of gastric cancer (GC). We first measured the plasma expression levels of 15 selected microRNAs (miR-1, -106a, -106b, -17-5p, -20a, -21, -221, -27a, -34, -376c, -378, -423-5p, -451, -486, -744) in 30 GC patients and 30 age- and gender-matched healthy controls and then validated those microRNAs that differentiating GC and controls in another 60 GC patients and 60 matched controls using quantitative reverse transcription-polymerase chain reaction. The areas under the receiver operating characteristic (ROC) curves were used to test the sensitivity and specificity of GC diagnosis using these identified plasma microRNAs. Three plasma microRNAs, miR-106b, miR-20a, and miR-221, were significantly elevated in GC patients than in healthy controls ( P < 0.05). Furthermore, the areas under the ROC curves using miR-106b, miR-20a, and miR-221 for GC diagnosis were 0.7733 (95 % CI, 0.7758-0.8409), 0.8593 (95 % CI, 0.8046-0.9139), and 0.7960 (95 % CI, 0.7256-0.8664), respectively. Furthermore, these three microRNAs had a statistically significant elevation in GC patients compared with healthy controls at each of the four stages. However, there were no significant differences in the plasma levels of the three microRNAs among the four TNM stages ( P > 0.05). Plasma miR-106b, miR-20a, and miR-221 have the potential as novel, non-invasive biomarkers for the early detection of GC.


Related Articles

  • MicroRNAs as Diagnostic Biomarkers in Gastric Cancer. Ying Yin; Jun Li; Shujie Chen; Tianhua Zhou; Jianmin Si // International Journal of Molecular Sciences;Oct2012, Vol. 13 Issue 10, p12544 

    Considering the high mortality rates and the unfavorable prognosis of gastric cancer (GC) as well as the lack of a clinical predictive marker, which is sufficiently sensitive to GC, it is of great significance to investigate new sensitive and specific markers for GC diagnosis. MicroRNAs (miRNAs)...

  • Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Liduan Zheng; Mixia Weng; Jun He; Xiuping Yang; Guosong Jiang; Qiangsong Tong // Virchows Archiv;Jan2010, Vol. 456 Issue 1, p53 

    Abstract  Resistin-like molecule beta (RELMβ), an intestinal goblet cell-specific protein, is a biomarker of intestinal metaplasia in Barrett’s esophagus and over-expressed in colon cancer. Since gastric adenocarcinomas can arise through a process of intestinalization, we...

  • CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer. Se-Il Go; Gyung Hyuck Ko; Won Sup Lee; Rock Bum Kim; Jeong-Hee Lee; Sang-Ho Jeong; Young-Joon Lee; Soon Chan Hong; Woo Song Ha // Cancer Research & Treatment;2016, Vol. 48 Issue 1, p142 

    Purpose: The present study is to investigate the significance of CD44 variant 9 (CD44v9) expression as a biomarker in primary gastric cancer. Materials and Methods: With various gastric tissues, we performed immunohistochemical staining for CD44v9. Results: The positive expression rates for...

  • Serum cytokeratin 18 as a biomarker for gastric cancer. Oyama, Katsunobu; Fushida, Sachio; Kinoshita, Jun; Okamoto, Koichi; Makino, Isamu; Nakamura, Keishi; Hayashi, Hironori; Inokuchi, Masafumi; Nakagawara, Hisatoshi; Tajima, Hidehiro; Fujita, Hideto; Takamura, Hiroyuki; Ninomiya, Itasu; Kitagawa, Hirohisa; Fujimura, Takashi; Ohta, Tetsuo // Clinical & Experimental Medicine;Nov2013, Vol. 13 Issue 4, p289 

    Cytokeratin 18 (CK18) fragments are released into circulation during epithelial cell death. M30 (reflects caspase-cleaved CK18 fragment) and M65 (reflects total CK18 fragment) enzyme-linked immunosorbent assay (ELISA) detect circulating CK18 fragments released during caspase-dependent or total...

  • miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Tan, Zhiqin; Jiang, Hao; Wu, Youhua; Xie, Liming; Dai, Wenxiang; Tang, Hailin; Tang, Sanyuan // Molecular & Cellular Biochemistry;Jan2014, Vol. 386 Issue 1/2, p223 

    miR-185 has been identified as an important factor in several cancers such as breast cancer, ovarial cancer, and prostate cancer. However, its effect and prognostic value in gastric cancer are still poorly known. In this study, we found that the expression levels of miR-185 were strongly...

  • Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients. Song, Jianning; Bai, Zhigang; Han, Wei; Zhang, Jun; Meng, Hua; Bi, Jintao; Ma, Xuemei; Han, Shiwei; Zhang, Zhongtao // Digestive Diseases & Sciences;Apr2012, Vol. 57 Issue 4, p897 

    Background: Circulating microRNA expression profiles may be promising biomarkers for diagnosis and assessment of the prognosis of cancer patients. Quantitative polymerase chain reaction (qPCR) is a sensitive technique for estimating expression levels of circulating microRNAs. However, there is...

  • MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Jiang, C; Chen, X; Alattar, M; Wei, J; Liu, H // Cancer Gene Therapy;Jun2015, Vol. 22 Issue 6, p291 

    MicroRNAs (miRNAs), which are small single-stranded RNA molecules composed of 18-23 nucleotides, act as oncogenes or tumor suppressor genes playing important roles in tumor formation, infiltration and metastasis. Subsequently, miRNAs expression contributes to cancer diagnosis and prognosis....

  • Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study. Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent...

  • Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis. Wang, Qi-Xian; Zhu, You-Qing; Zhang, Hu; Xiao, Jun // Cellular Physiology & Biochemistry (Karger AG);Feb2015, Vol. 35 Issue 3, p933 

    Background/Aims: Aberrant microRNA expression has the potential to be used for early diagnosis of gastric cancer or to predict survival and treatment response. This study performed a systematic review and meta-analysis of altered miRNAs in gastric cancer in order to assess the use of miRNAs as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics